82 FR 58606 - Proposed Data Collection Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 238 (December 13, 2017)

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Focus Group Testing to Effectively Plan and Tailor Cancer Prevention and Control Communication Campaigns. Thus, CDC seeks to request Office of Management and Budget (OMB) approval to reinstatement OMB Control Number 0920-0800.

[Federal Register Volume 82, Number 238 (Wednesday, December 13, 2017)]
[Notices]
[Pages 58606-58607]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-26783]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-0800; Docket No. CDC-2017-0113]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Focus Group Testing to 
Effectively Plan and Tailor Cancer Prevention and Control Communication 
Campaigns. Thus, CDC seeks to request Office of Management and Budget 
(OMB) approval to reinstatement OMB Control Number 0920-0800.

DATES: CDC must receive written comments on or before February 12, 
2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0113 by any of the following methods:
    Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION: To request more information on the proposed 
project or to obtain a copy of the information collection plan and 
instruments, contact Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Focus Group Testing to Effectively Plan and Tailor Cancer 
Prevention and Control Communications Campaigns--(OMB No. 0920-0800, 
exp. 12/31/2017)--Reinstatement without Change--National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    The mission of the CDC's Division of Cancer Prevention and Control 
(DCPC) is to reduce the burden of cancer in the United States through 
cancer prevention, reduction of risk, early detection, better 
treatment, and improved quality of life for cancer survivors. Toward 
this end, the DCPC supports the scientific development and 
implementation of various health communication campaigns with an 
emphasis on specific cancer burdens.
    This process requires testing of messages, concepts, and materials 
prior to their final development and dissemination, as described in the 
second step of the health communication process. The health 
communication process is a scientific model developed by the U.S. 
Department of Health and Human Services' National Cancer Institute to 
guide sound campaign development. The communication literature supports 
various data collection methods, one of which is focus groups, to 
conduct credible formative, concept, message, and materials testing. 
The purpose of focus groups is to ensure that the public and other key 
audiences, like health professionals, clearly understand cancer-
specific information and concepts, are motivated to take the desired 
action, and do not react negatively to the messages.
    CDC is currently approved to collect information needed to plan and 
tailor cancer communication campaigns (OMB No. 0920-0800, expiration 
date 12/31/2017), and seeks OMB approval to extend the existing generic 
clearance.
    Information collection will involve focus groups to assess numerous 
qualitative dimensions of cancer prevention and control messages 
including, but not limited to, cancer knowledge, attitudes, beliefs, 
behavioral intentions, information needs and sources, clinical 
practices (among healthcare providers), and compliance with recommended 
cancer screening. Insights gained from the focus groups will assist in 
the development and/or refinement of future campaign messages and 
materials.
    Respondents will include healthcare providers as well as members of 
the general public. Communication campaigns and messages will vary 
according to the type of cancer, the qualitative dimensions of the 
message described above, and the type of respondents.
    DCPC plans to conduct or sponsor up to 80 focus groups per year 
over a three-year period. An average of 10 respondents will participate 
in each

[[Page 58607]]

focus group discussion. DCPC has developed a set of example questions 
that can be used to develop a discussion guide for each focus group 
activity. The average burden for response for each focus group will be 
two hours. DCPC has also developed a set of example questions that can 
be tailored to screen for targeted groups of respondents. The average 
burden per response for screening and recruitment is three minutes.
    A separate information collection request will be submitted to OMB 
for approval of each focus group activity. The request will describe 
the purpose of the activity and include the customized information 
collection instruments.
    OMB approval is requested for three years. There are no changes to 
information collection purpose or methodology. Participation is 
voluntary and there are no costs to respondents except their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
General Public................  Screening Form..             960               1            3/60              48
General Public................  Focus Group                  480               6               2             960
                                 Guide.
Health Care Professionals.....  Screening Form..             640               1            3/60              32
Health Care Professionals.....  Focus Group                  320               1               2             640
                                 Guide.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           1,680
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-26783 Filed 12-12-17; 8:45 am]
 BILLING CODE 4163-18-P